Wockhardt Ltd Share Price
(WOCKPHARMA)
₹1465.2▲3.58%
as on 04:01PM, 24 Apr 2025
Wockhardt Performance
Day's Low
Day's High
₹1,407.7Day's Price Range₹1,529.452 Week's Low
52 Week's High
₹490.1552-Week Price Range₹1,679.9
| Returns % | |
| 1 Month Return | + 2.71 % |
| 3 Month Return | + 14.89 % |
| 1 Year Return | + 156.76 % |
| Market Stats | |
| Previous Close | ₹1,414.60 |
| Open | ₹1,413.00 |
| Volume | 11.49L |
| Upper Circuit | ₹1,556.00 |
| Lower Circuit | ₹1,273.20 |
| Market Cap | ₹23,807.39Cr |
Wockhardt Fundamentals
P/E Ratio
-111.42
PEG Ratio
-5.15
Market Cap
₹23,807.39 Cr
P/B Ratio
5
EPS
-30.65
Dividend Yield
0Sector
Pharmaceuticals
ROE
0Mutual Fund Holdings of Wockhardt
Key events for Wockhardt Ltd
Wockhardt Faces Tariff Challenges Amid Breakthroughs - 12 Apr, 2025
Dr. Huzaifa Khorakiwala of Wockhardt Ltd highlighted potential challenges from US tariffs on Indian pharma. Despite this, Wockhardt leads in antibiotic research, with promising results from its WCK-5222-ZENIC trial.Wockhardt to Exit US Generics Business - 07 Apr, 2025
Wockhardt has announced its decision to exit the remaining US generics business for commercial reasons. The company reported a loss of ₹7 crore in Q3FY24 due to restructuring. Shares fell by 10% to ₹1,212.80.Wockhardt Shifts Focus to Novel Antibiotics and Biosimilars - 03 Apr, 2025
Wockhardt Ltd is pivoting from generics to novel antibiotics, seeking FDA approval for Zaynich, which shows promising results. The company anticipates significant revenue growth with new drugs and a turnaround in profitability.Wockhardt Shares Surge After Zaynich Success - 01 Apr, 2025
Wockhardt's shares climbed nearly 3% following the successful compassionate use of its antibiotic Zaynich in treating a 15-year-old cancer patient with a severe infection. This marks the third successful case for Zaynich, which has shown promise against drug-resistant infections and completed Phase III trials.Wockhardt Shares Surge on Drug Efficacy News - 19 Mar, 2025
Wockhardt Pharmaceuticals' shares hit a 5% upper circuit at ₹1,421 after its Zaynich drug demonstrated a 96.8% clinical cure rate in a Phase III study. The stock has risen 162% over the past year, outperforming benchmarks and peers.
Insights on Wockhardt Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 6 months, WOCKPHARMA stock has moved up by 26.1%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, WOCKPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 34.39% to 34.53% in Dec 2024 quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, WOCKPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 7.09% to 7.13% in Dec 2024 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -22.0 Cr → 14.0 Cr (in ₹), with an average increase of 257.1% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 49.09% of holdings in Dec 2024 quarter
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 818.0 Cr → 729.0 Cr (in ₹), with an average decrease of 10.9% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 6.61% to 6.54% in Dec 2024 quarter
Wockhardt Financials
Wockhardt Index Inclusions
Wockhardt Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 49.09% | 0.00 | |
| Foreign Institutions | 6.54% | ||
| Mutual Funds | 7.13% | 0.58 | |
| Retail Investors | 34.53% | 0.40 | |
| Others | 2.71% |
Wockhardt Key Indicators
Wockhardt Valuation
Wockhardt in the last 5 years
Lowest (-125.67x)
February 5, 2025
Today (-111.42x)
April 24, 2025
Industry (54.50x)
April 24, 2025
Highest (12.70x)
May 26, 2021
Wockhardt Earnings and Dividends
Wockhardt Ltd Earnings Results
Wockhardt Ltd’s net profit jumped 116.87% since last year same period to ₹14Cr in the Q3 2024-2025. On a quarterly growth basis, Wockhardt Ltd has generated 163.64% jump in its net profits since last 3-months.
Read More about Earnings ResultsWockhardt Ltd Dividends November,2016
In the quarter ending September 2016, Wockhardt Ltd has declared dividend of ₹10 - translating a dividend yield of 0.68%.
Read More about Dividends
Wockhardt Technicals Summary
Bearish
Neutral
Bullish
Wockhardt Ltd is currently in a Bullish trading position according to technical analysis indicators.
Wockhardt Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹23,807.39 Cr | 99.06% | 0.77 | -₹472 Cr | ₹2,798 Cr | |
| BUY | ₹30,669.99 Cr | 144.67% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
| BUY | ₹15,175.71 Cr | 31.35% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
| NA | ₹5,029.76 Cr | 2.21% | 0.79 | -₹388 Cr | ₹75 Cr | |
| BUY | ₹14,577.74 Cr | 43.77% | 0.68 | ₹218 Cr | ₹1,296 Cr |
About Wockhardt
Revenue: ₹721.00Cr as on December 2024 (Q4 24)
Net Profit: ₹20.00Cr as on December 2024 (Q4 24)
Listing date: 23 Feb, 2000
Chairperson Name: H F Khorakiwala
| Organisation | Wockhardt |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Wockhardt Ltd
What is Wockhardt Ltd price today?
Wockhardt Ltd share price today stands at ₹1465.2, Open: ₹1413, Previous Close: ₹1414.6, High: ₹1529.4, Low: ₹1407.7, 52 Week High: ₹1679.9, 52 Week Low: ₹490.15.
How to Buy Wockhardt Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Wockhardt Ltd shares
What are today's traded volumes of Wockhardt Ltd?
Today's traded volume of Wockhardt Ltd(WOCKPHARMA) is 11.49L.
What is today's market capitalisation of Wockhardt Ltd?
Today's market capitalisation of Wockhardt Ltd(WOCKPHARMA) is ₹23807.39Cr.
What is the 52 Week High and Low Range of Wockhardt Ltd?
How much percentage Wockhardt Ltd is down from its 52 Week High?
Wockhardt Ltd (WOCKPHARMA) share price is ₹1465.2. It is down -12.78% from its 52 Week High price of ₹1679.9
How much percentage Wockhardt Ltd is up from its 52 Week low?
Wockhardt Ltd (WOCKPHARMA) share price is ₹1465.2. It is up 198.93% from its 52 Week Low price of ₹490.15